articles+ search results
109 articles+ results
1 - 20
Next
-
Mohamed S.H. Hassan, Ahmed Ali, Motamed Elsayed Mahmoud, Danah Altakrouni, Shahnas M. Najimudeen, and Mohamed Faizal Abdul-Careem
- Virus Research, Vol 339, Iss , Pp 199281- (2024)
- Subjects
-
Infectious bronchitis virus (IBV), DMV/1639, Autogenous vaccine, Layer, Canada, Microbiology, QR1-502, Infectious and parasitic diseases, and RC109-216
- Abstract
-
The emergence of the Canadian Delmarva (DMV)/1639 infectious bronchitis virus (IBV) type strains was associated with egg production disorders in Eastern Canadian layer operations. While developing vaccines for novel IBV variants is not typically a reasonable approach, the consideration of an autogenous vaccine becomes more appealing, particularly when the new variant presents significant economic challenges. The current study aimed to compare the efficacies of two vaccination programs that included heterologous live priming by Massachusetts (Mass) and Connecticut (Conn) type vaccines followed by either a commercial inactivated Mass type vaccine or a locally prepared autogenous inactivated DMV/1639 type vaccine against DMV/1639 IBV challenge. The protection parameters evaluated were egg production, viral shedding, dissemination of the virus in tissues, gross and microscopic lesions, and immunological responses. The challenge with the DMV/1639 caused severe consequences in the non-vaccinated laying hens including significant drop in egg production, production of low-quality eggs, serious damage to the reproductive organs, and yolk peritonitis. The two vaccination programs protected the layers from the poor egg-laying performance and the pathology. The vaccination program incorporating the autogenous inactivated DMV/1639 type vaccine was more effective in reducing vial loads in renal and reproductive tissues. This was associated with a higher virus neutralization titer compared to the group that received the commercial inactivated Mass type vaccine. Additionally, the autogenous vaccine boost led to a significant reduction in the viral shedding compared to the non-vaccinated laying hens. However, both vaccination programs induced significant level of protection considering all parameters examined. Overall, the findings from this study underscore the significance of IBV vaccination for protecting laying hens.
- Full text View on content provider's site
-
Dalia A. Gaber, Mahasen A. Radwan, Danah A. Alzughaibi, Jenan A. Alail, Rafa S. Aljumah, Reema M. Aloqla, Sara A. Alkhalifah, and Siham A. Abdoun
- Drug Delivery, Vol 30, Iss 1 (2023)
- Subjects
-
Nanosponges, crosslinker, nanocarrier, cyclodextrin, analgesics, drug efficacy, Therapeutics. Pharmacology, and RM1-950
- Abstract
-
AbstractCyclodextrin nanosponges are solid nanoparticles, designed by cross-linking of cyclodextrin polymer; it has been used widely as a good delivery system for water insoluble drugs. The aim of this study is to enhance the solubility of Piroxicam (PXM) using β-Cyclodextrin based nanosponges formulations. PXM nanosponge (PXM-NS) formulations were prepared using β-cyclodextrin and carbonyldiimidazole as a cross linker, three ratios of β-cyclodextrin to crosslinker in addition to three drug to nanosponges ratios were tested. Piroxicam nanosponge formulations were characterized for its particle size, zeta potential, physical compatibility and in vitro release. Stability studies at three temperatures (4 °C, 25 °C and 40 °C) were done for optimal formula. Finally, the in vivo analgesic activity and pharmacokinetic parameters of the optimal formula were conducted. The optimized PXM-NS formula (PXM-NS10) showed particle size (362 ± 14.06 nm), polydispersity index (0.0518), zeta potential (17 ± 1.05 mV), and %EE (79.13 ± 4.33). The dissolution study showed a significant increase in the amount of PXM dissolved compared with the unformulated drug. Stability studies confirmed that nanosponge showed accepted stability for 90 days at 4 °C and 25 °C. In vivo analgesic studies verified that there was a significant enhancement in the analgesic response to PXM in mice, and 1.42 fold enhancement in the relative bioavailability of PXM-NS10 as compared to commercial tablets. Nanosponge prepared under optimal conditions is an encouraging formula for increasing the solubility and therefore the bioavailability of Piroxicam.
- Full text View on content provider's site
-
Danah A. Du Preez, Abiodun Mayowa Akanmu, Festus Adeyemi Adejoro, and Abubeker Hassen
- Animals, Vol 13, Iss 22, p 3514 (2023)
- Subjects
-
feed additives, plant secondary metabolites, rumen fermentation, toxicity, Veterinary medicine, SF600-1100, Zoology, and QL1-991
- Abstract
-
Plant secondary compounds are potential rumen modifiers that can improve nutrient utilization in ruminant animals. This study evaluated the effect of Moringa (Moringa oleifera) and Neem (Azadirachta indica) leaf extracts on nutrient digestibility, growth performance, and enteric methane production in South African Mutton Merino lambs. Forty 4-month-old ram lambs with a mean body weight of 35 ± 2.2 kg were blocked by weight and from each block, lambs were randomly allocated into one of the following treatments: (i) diet only (fed a total mixed ration TMR-negative control), (ii) Monensin (fed TMR containing Monensin sodium, 15 mg/kg DM), (iii) Moringa (fed TMR, drenched with Moringa extract 50 mg/kg feed DM intake), and (iv) Neem (fed TMR, drenched with Neem extract 50 mg/kg DM intake). Extracts were administered via oral drenching at a concentration determined based on the previous week’s feed intake. There were no differences in dry matter intake, average daily gain, feed conversion efficiency, digestibility, and nitrogen retention across the treatments. However, the extracts tended to reduce methane emitted both in g/head/day (p < 0.08) and g/ kg dry matter intake (p < 0.07). Extracts did not influence any of the blood metabolites in the ram lambs. Although the benefits of utilizing these medicinal plants as rumen modifiers under prolonged feeding conditions is justified, further evaluation is recommended to test Moringa and Neem leaf extracts at higher inclusion levels. Our research group is currently exploring a variety of phytogenic tools for the identification and standardization of key bioactive compounds linked to methane inhibition, in these leaf extracts.
- Full text
View/download PDF
-
Danah S. Alharbi, Shouq F. Albalawi, Sarah T. Alghrid, Basma S. Alhwity, Mona Qushawy, Yasmin Mortagi, Mohamed El-Sherbiny, Kousalya Prabahar, and Nehal Elsherbiny
- Foods, Vol 12, Iss 22, p 4139 (2023)
- Subjects
-
ginger oil, nanoemulsion, Ehrlich’s ascites carcinoma, apoptosis, tumor, breast cancer, Chemical technology, and TP1-1185
- Abstract
-
Cancer is a disease that is characterized by uncontrolled cell proliferation. Breast cancer is the most prevalent cancer among women. Ginger oil is a natural cancer fighter and anti-oxidant. However, the minimal absorption of ginger oil from the gastrointestinal tract accounts for its limited medicinal efficacy. The present study was designed to evaluate the efficacy of a nanoemulsion preparation of ginger oil on its oral bioavailability and in vivo anti-cancer efficacy. Ginger oil nanoemulsion was prepared by a high-pressure homogenization technique using different surfactants (Tween 20, 40, and 80). The prepared formulations were evaluated for droplet size, polydispersity index (PDI), zeta potential (ZP), pH, viscosity, and stability by calculating the creaming index percentage. The best formulation was evaluated for shape by TEM. The antitumor activity of the best nano-formulation was determined in comparison with the free oil using the in vivo Ehrlich solid tumor (EST) model. The prepared ginger oil nanoemulsion formulations exhibited acceptable droplet size in the range from 56.67 ± 3.10 nm to 357.17 ± 3.62 nm. A PDI of less than 0.5 indicates the homogeneity of size distribution. The oil globules possessed a negative charge ranging from −12.33 ± 1.01 to −39.33 ± 0.96 mV. The pH and viscosity were in the acceptable range. The TEM image of the best formulation appeared to be spherical with a small size. The ginger oil nanoemulsion reduced in vivo tumor volume and weight, extended animals’ life span, and ameliorated liver and kidney function in EST-bearing mice. These effects were superior to using free ginger oil. Collectively, the present study demonstrated that the ginger oil nanoemulsion improved oral absorption with a subsequent enhancement of its anti-proliferative efficacy in vivo, suggesting a nano-formulation of ginger oil for better therapeutic outcomes in breast cancer patients.
- Full text View on content provider's site
-
Azra Zafar and Danah Aljaafari
- Heliyon, Vol 9, Iss 11, Pp e22393- (2023)
- Subjects
-
Science (General), Q1-390, Social sciences (General), and H1-99
- Abstract
-
Introduction: Nonconvulsive status epilepticus (NCSE) is an important and often unrecognized cause of impaired awareness especially in critically ill patients, which can easily be missed. Electroencephalography (EEG) findings in clinically suspected cases are the mainstay of diagnosis. Review summary: The EEG diagnostic criteria for NCSE have evolved over the past three decades. Furthermore, recent advancements in EEG technologies such as continuous EEG monitoring, and emergency department EEG, along with development of different diagnostic criteria, have increased the detection rate for NCSE in suspected cases. However, treating physicians should have a higher index of clinical suspicion and a lower threshold for recommending this valuable investigation. The introduction of different diagnostic criteria has made it easier for electroencephalographers to report NCSE; nevertheless, diagnosis is not always straightforward. This narrative review aimed to define and discuss the available literature on different EEG diagnostic criteria for NCSE. Conclusion: There is a need for further prospective research to strengthen the diagnostic accuracy of the available diagnostic criteria, the modified Salzburg Consensus Criteria for NCSE (mSCNC) and updated American Clinical Neurophysiology Society (ACNS) 21 criteria, to verify their accuracy to detect NCSE in comatose patients.
- Full text View on content provider's site
-
Yacoub A. Yousef, Isra M. Sid Ahmed, Danah Kanj Ahmad, Mona Mohammad, Hala Makahleh, Reem AlJabari, Fawzieh Alkhatib, Mario Damiano Toro, Robert Rejdak, Mustafa Mehyar, and Ibrahim Alnawaiseh
- Journal of Clinical Medicine, Vol 12, Iss 22, p 7140 (2023)
- Subjects
-
optic disc swelling, papilledema, chemotherapy, infiltration, Jordan, and Medicine
- Abstract
-
Purpose: To analyze the etiology and implications of optic disc swelling in cancer patients treated at a specialized tertiary cancer center in Jordan. Methods: This was a retrospective study of all cancer patients who had optic disc swelling between January 2019 and December 2020 at King Hussein Cancer Center (KHCC). Patients’ data included age, sex, laterality, visual acuity, and the underlying cause and management for the optic disc swelling. Results: Optic disc swelling was present in 58 cancer patients (96 eyes), with 38 (65%) having bilateral involvement. Among these, 33 (57%) were female, and 43 (74%) were ≤40 years old. At diagnosis, 58 (63%) eyes had a best-corrected visual acuity (BCVA) better than 0.5, improving to 73 (76%) eyes at the last follow-up. High intracranial pressure (ICP) was the most common primary cause (30 patients/52%), followed by tumor infiltration of the optic nerve (10 patients/17%), optic nerve compression (7 patients/12%), and optic nerve inflammation (5 patients/9%). Four patients had pseudopapilledema. Among the 30 patients with high ICP, CNS tumors were predominant (21 patients/70%), with only 3 having idiopathic intracranial hypertension. Medications, including ATRA (All-Trans Retinoic Acid) and systemic steroids, contributed to increased ICP in six patients (20%). BCVA was less than 0.5 in all eyes (100%) affected by tumor infiltration, optic nerve inflammation, and ischemic optic neuropathy, while only eight eyes (14%) with optic disc swelling due to elevated ICP had a BCVA less than 0.5 (p < 0.0001). Management included steroids (53 patients/91%), acetazolamide (30 patients/52%), chemotherapy (20 patients/34%), radiation therapy (13 patients/22%), frequent lumbar punctures (12 patients/21%), and surgery (28 patients/48%). Visual acuity improved in 40 eyes (42%), with only 4 eyes (4%) experiencing deterioration. At a 12-month median follow-up period, 11 (19%) patients were dead, 10 (10%) eyes had poor vision (BCVA less than 0.1), and 21 (22%) eyes had BCVA 0.5 or better. Conclusions: Various underlying pathologies can induce optic disc swelling in cancer patients, a grave condition capable of causing vision loss. Notably, tumor infiltration of the optic nerve tends to result in more profound visual impairment compared to papilledema due to elevated ICP. Timely detection is crucial, and immediate symptomatic treatment followed by addressing the underlying cause is essential to prevent irreversible optic nerve damage and vision loss in cancer patients.
- Full text View on content provider's site
-
Abdulaziz M. F. Shayea, Amna A. Alshatti, Danah H. Alfadhli, Almutairi Fatimah Ibrahim, Mariam Kh. Almutairi, and Mohammed Sh. Nadar
- Journal of Orthopaedic Surgery and Research, Vol 18, Iss 1, Pp 1-17 (2023)
- Subjects
-
Trigger fingers, Metabolic syndrome, Smoking, inflammation, Orthopedic surgery, RD701-811, Diseases of the musculoskeletal system, and RC925-935
- Abstract
-
Abstract Purpose To investigate the health-related factors and analyze the expression of epigenetic related genes and inflammatory genes in metabolic syndrome Trigger Finger (TF) and smoker TF. Methods Samples from patients’ fingers with symptomatic TF were collected. There were seven groups: healthy control group, carpal tunnel syndrome (as a control for gene expression analysis), TF, diabetic TF, hypertensive TF, dyslipidemic TF and smoker TF. The expression levels of epigenetic related genes and inflammatory genes in metabolic syndrome TF and smoker TF were evaluated by the reverse transcription–polymerase chain reaction (RT-PCR) technique. The Perceived Stress Scale (PSS), Pittsburgh Sleep Quality Index (PSQI) questionnaires, disability of the arm, shoulder and hand (DASH) and numeric pain rating scale were given to the participants to fill out. Results There was a significant increase in hand dysfunction in the metabolic TF groups and smoker group compared to the TF group (p
- Full text View on content provider's site
-
Danah ALRabeeah, Aliyah Almomen, Nourah Alzoman, and Maria Arafah
- Saudi Pharmaceutical Journal, Vol 31, Iss 10, Pp 101758- (2023)
- Subjects
-
Anti-Epileptic drugs, Levetiracetam, Pharmacokinetics, Liver enzymes, High-performance liquid chromatography, Saudi Arabia, Therapeutics. Pharmacology, and RM1-950
- Abstract
-
Background: Epilepsy is a common global neurological disorder. About 30% of epileptic patients are managed with anti-epileptic Drugs (AEDs). Since 2000, Levetiracetam (LEV) has been marketed around the world as an AED under the brand name Keppra, and recently more generics are found in the Saudi market as cheaper alternatives. The objective of this study is to evaluate the bioequivalence of LEV brand and generics available in the Saudi market in mice. Methods: Pharmacokinetics (PK), liver function test, and behavioral studies were conducted for LEV brand and generic in different groups of Blab/c mice. Results: PK results show a significance difference in PK parameters mostly evidenced with generic 3, then generic 2. The only significant different between Keppra and generic 1 was in T1/2. In addition, Keppra did not significantly increase liver enzymes in comparison to other generics. On the other hand, other generics showed less favorable results in increasing liver enzymes. Keppra reduced the number and intensity of epileptic attacks, had no mortality rate due to epilepsy, and was associated with less sever seizures attacks. Conclusion: Keppra, the brand form of LEV, has better safety and efficacy profiles in mice compared to 3 generics found in the Saudi market. Therefore, we recommend evaluating the same parameters tested in this study in patients utilizing similar generics and brand to establish the existence of bioequivalence between LEV brand and generics.
- Full text View on content provider's site
-
Tharwa Bilbeisi, Razaq Almasry, Mariam Obeidat, Mona Mohammad, Imad Jaradat, Hadeel Halalsheh, Ayat Alni’mat, Danah Kanj Ahmad, Nour Alsaket, Mustafa Mehyar, Ibrahim Al-Nawaiseh, and Yacoub A. Yousef
- Frontiers in Medicine, Vol 10 (2023)
- Subjects
-
death, Jordan, metastasis, retinoblastoma, survival, Medicine (General), and R5-920
- Abstract
-
PurposeTo analyze causes and prognostic factors for death among Retinoblastoma (Rb) patients treated at a single specialized tertiary cancer center in Jordan.MethodsWe reviewed the mortality causes for all Rb patients who have been treated at the King Hussein Cancer Center between 2003 and 2019 and were followed for at least 3 years after diagnosis. The main outcome measures included demographics, laterality, tumor stage, treatment modalities, metastasis, survival, and causes of death.ResultsTwenty-four (5%) of the 478 patients died from retinoblastoma and 5-year survival was 94%. The mean age at diagnosis was 15 months (median, 18 months; range, 4–38 months); eight (33%) received diagnoses within the first year of life. Eleven (46%) were boys, 16 (67%) had bilateral disease, and 3 (13%) had a positive family history. The stage for the worst eye was C for 1 (4%) patient, D in 6 (25%) patients, and E (T3) in 15 (63%) patients. Two patients had extraocular Rb at diagnosis, and four of the patients who had intraocular Rb at diagnosis refused treatment and then came back with extraocular Rb. In total, extraocular disease was encountered in six eyes (six patients). After a 120-month median follow-up period, 24 patients (5%) died of second neoplasms (n = 3) or metastases (n = 21). Significant predictive factors for metastasis and death included advanced IIRC tumor stage (p
- Full text View on content provider's site
-
Azra Zafar, Aishah Albakr, Rizwana Shahid, Fahd Alkhamis, Majed Alabdali, Danah Aljaafari, Saima Nazish, Foziah Jabbar Gossab AlShamrani, Erum Shariff, Mohammad Zeeshan, Abdulla AlSulaiman, Abdullah Saleh AlAmri, Anas Salman Aldehailan, and Hosam Al-Jehani
- Frontiers in Neurology, Vol 14 (2023)
- Subjects
-
glycated hemoglobin, HbA1c level, acute ischemic stroke, intracranial large artery atherosclerotic disease, functional outcomes, predictor, Neurology. Diseases of the nervous system, and RC346-429
- Abstract
-
ObjectiveThis study aimed to investigate the effect of the glycated hemoglobin A1c (HbA1c) level on the functional outcome (FOC) in patients with intracranial large artery atherosclerotic disease (ICLAD)-related acute ischemic stroke (AIS).MethodsThis retrospective study enrolled patients with ICLAD-related AIS who were admitted to King Fahd University Hospital between January 2017 and September 2021. Patients were divided into two groups based on the optimal cutoff HbA1c level determined using receiver operating characteristic curve analysis—those with HbA1c ≤6.9% and those with HbA1c >6.9%. Demographic and other clinical characteristics were compared between the two groups using chi-square tests. The association between HbA1c and 90-day FOC was assessed using the chi-square test and odds ratios (ORs). Multivariate analysis was performed to adjust for confounding factors.ResultsA total of 140 patients were included in the analysis. A significant association was observed between the HbA1c level and FOC. Compared to patients with HbA1c ≤6.9%, patients with HbA1c >6.9% were more likely to have an unfavorable FOC [p = 6.9% and unfavorable FOC was sustained even after adjusting for confounding factors (p = 0.008) and atherosclerosis risk factors (p = 0.01). HbA1c >6.9% was also associated with higher ORs for in-hospital complications (p = 0.06, OR = 1.34, 95% CI = 1.02–1.77) and mortality (p = 0.07, OR = 1.42, 95% CI = 1.06–1.92) although these associations did not attain significant p-values.ConclusionHbA1c >6.9% was significantly associated with unfavorable FOC in ICLAD-related AIS. However, further studies with larger sample sizes are required to verify whether HbA1c is an independent predictor of poor FOC. Nevertheless, targeting HbA1c
- Full text View on content provider's site
-
Pierre Moreau, Mohammad Qaddoumi, Dalal Al-Taweel, Sarah Alghanem, Tania Bayoud, Maryam Alowayesh, Monerah Al-Soraj, Mohsen Hedaya, Asmaa Al-Haqan, and Danah Alsane
- Pharmacy, Vol 11, Iss 5, p 149 (2023)
- Subjects
-
competency-based, pharmacy, education, matrix competency framework, Kuwait, entrustable professional activities (EPA), Pharmacy and materia medica, and RS1-441
- Abstract
-
The development of competency frameworks serves as the foundation for the development of competency-based education. It is vital to develop a country-specific framework to address the specific needs of the local population for pharmacy services. This study aimed to describe the development process of a competency framework for undergraduate pharmacy education in Kuwait with a unique matrix structure. The process started with the development of guiding principles for curriculum revision and implementation, as well as the identification of global educational outcomes. This process was followed by: (A) a needs assessment with key stakeholders; (B) development of the initial competency framework; and (C) refinement of the framework. Qualitative data were thematically analyzed to identify the main competency domains that students need to perform the identified entrustable professional activities (EPAs). Five population needs were identified by the needs assessment, with 17 EPAs suggested to fulfill those needs. In addition, 11 competency domains were identified. The initial competency framework was created as a 3 × 8 matrix, with 3 professional and 8 transversal competency domains. Refinement of the framework resulted in the removal of redundancies and the development of a global behavior competency profile. The development of a matrix competency framework and associated EPAs for Kuwait serves as a foundation for preparing pharmacists to fulfill local population needs and expanding the scope of practice in the country.
- Full text View on content provider's site
-
Hatan Mortada, MBBS, Khalid Murrad, MBBS, Danah Alkadi, MBBS, Ahmed AlAbdali, MBBS, Hamzah Ali Alhamzah, MBBS, MPH, FRCS(C), and Abdullah Kattan, MD, FRCS(C)
- Plastic and Reconstructive Surgery, Global Open, Vol 11, Iss 9, p e5277 (2023)
- Subjects
-
Surgery and RD1-811
- Abstract
-
Summary:. Silicone liquid (polydimethylsiloxane) is an inert material commonly used for cosmetic purposes. A combination of both systematic and local devastating complications can cause end-organ toxicity and multi-organ dysfunction. In this article, we examine the literature and present a case of a patient who presented with lower extremity filler migration and granuloma formation 11 years post gluteal silicone injection. A 31-year-old woman who had received a gluteal silicone injection 11 years ago was experiencing painful erythema, progressive fibrosis, and swelling as the result of the injection. The patient was diagnosed with postfiller autoimmune syndrome. Multiple surgical interventions were conducted to remove the permanent filler from her left knee. As a result of multiple surgical sessions, the patient has been managed successfully with no relapses. This case demonstrated complications of an unusual silicone injection technique for gluteal augmentation. Despite silicone being considered inert, complications can arise years after injection, necessitating extensive medical intervention. This case also raises questions regarding the systemic effects of silicone fillers, warranting further research. Through this report, we aimed to enhance awareness and management of similar future cases.
- Full text View on content provider's site
-
Abdulaziz Saad Alshahrani, Danah Mohammad, Mohammad attieh Alzahrani, and Neeraj Narula
- Saudi Pharmaceutical Journal, Vol 31, Iss 9, Pp 101736- (2023)
- Subjects
-
Clostridium difficile infection (CDI), Vedolizumab, Crohn’s disease, Ulcerative colitis, Inflammatory bowel disease, 5- Aminosalicylates acid, Therapeutics. Pharmacology, and RM1-950
- Abstract
-
Introduction: Several studies have shown increased incidence, recurrence, and severity of Clostridium difficile infection (CDI) over the last decade. Patients with inflammatory bowel disease (IBD) who develop CDI are more prone to morbidity and mortality than CDI in patients without IBD. This study seeks to evaluate whether IBD patients who use vedolizumab are at increased risk of CDI compared to IBD patients using other therapies. Methods: This was a retrospective cohort study, and 684 patients with confirmed IBD (228 on vedolizumab, 228 on anti-TNF, and 228 on 5- Aminosalicylates acid therapy) were enrolled from January 2009 to August 2019 at a tertiary referral IBD center at McMaster University Medical Centre (MUMC) in Hamilton, Ontario, Canada. The primary outcome was time to the development of CDI in IBD patients using different therapies. Secondary outcomes included rates of CDI and the association between baseline variables and risk of CDI. A Cox proportional hazards (PH) model was used to evaluate baseline factors and development of CDI. Result: There was no difference in time to CDI between the three treatment groups (log rank p-value 0.37). CDI occurred in 16 patients (2.3%), specifically four patients (1.75%) in the vedolizumab group, four patients (1.75%) in the anti-TNF group, and eight patients (3.5%) in the 5-ASA group. The Cox PH model found current smoking, older age, and concomitant immunomodulator use as risk factors for CDI, after adjustment for other covariates. Vedolizumab was not associated with increased risk of CDI in the model. Conclusion: Biologic therapy with vedolizumab or anti-TNF did not impact risk of CDI. Risk factors for CDI in IBD patients included smoking, older age at the onset of medication, and immunomodulator therapy. Clinicians should have high degree of suspicion for CDI in IBD patients presenting with diarrhea, particularly in those with risk factors identified in this study.
- Full text View on content provider's site
-
Mohammed Imran Basheer Ahmed, Linah Saraireh, Atta Rahman, Seba Al-Qarawi, Afnan Mhran, Joud Al-Jalaoud, Danah Al-Mudaifer, Fayrouz Al-Haidar, Dania AlKhulaifi, Mustafa Youldash, and Mohammed Gollapalli
- Sustainability, Vol 15, Iss 18, p 13990 (2023)
- Subjects
-
Artificial Intelligence, PPE detection, computer vision, object detection, mAP score, Environmental effects of industries and plants, TD194-195, Renewable energy sources, TJ807-830, Environmental sciences, and GE1-350
- Abstract
-
Personal protective equipment (PPE) can increase the safety of the worker for sure by reducing the probability and severity of injury or fatal incidents at construction, chemical, and hazardous sites. PPE is widely required to offer a satisfiable safety level not only for protection against the accidents at the aforementioned sites but also for chemical hazards. However, for several reasons or negligence, workers may not commit to and comply with the regulations of wearing the equipment, occasionally. Since manual monitoring is laborious and erroneous, the situation demands the development of intelligent monitoring systems to offer the automated real-time and accurate detection of PPE compliance. As a solution, in this study, Deep Learning and Computer Vision are investigated to offer near real-time and accurate PPE detection. The four colored hardhats, vest, safety glass (CHVG) dataset was utilized to train and evaluate the performance of the proposed model. It is noteworthy that the solution can detect eight variate classes of the PPE, namely red, blue, white, yellow helmets, head, person, vest, and glass. A two-stage detector based on the Fast-Region-based Convolutional Neural Network (RCNN) was trained on 1699 annotated images. The proposed model accomplished an acceptable mean average precision (mAP) of 96% in contrast to the state-of-the-art studies in literature. The proposed study is a potential contribution towards the avoidance and prevention of fatal/non-fatal industrial incidents by means of PPE detection in real-time.
- Full text View on content provider's site
-
Danah Alothman, Edward Tyrrell, Sarah Lewis, Timothy Card, and Andrew William Fogarty
- The Lancet Regional Health. Europe, Vol 32, Iss , Pp 100695- (2023)
- Subjects
-
Analgesics, Pain, Suicide, Pregabalin, Gabapentin, Anticonvulsants, Public aspects of medicine, and RA1-1270
- Abstract
-
Summary: Background: Analgesics prescriptions may provide a marker for identifying individuals at higher risk of suicide. In particular, awareness of which analgesics are implicated may help clinicians assess and modify risk. Method: A case–control study in England using the Clinical Practice Research Datalink (for primary care records) linked with hospital and national mortality electronic registries. We included patients aged ≥15 who died by suicide between 2001 and 2019 (N = 14,515), to whom we individually matched 580,159 controls by suicide date and general practice (N = 594,674). Odds ratios (ORs) for suicide, controlled for age and sex, were assessed using conditional logistic regression. Findings: Suicide risks were highest in those prescribed adjuvant analgesics (pregabalin, gabapentin and carbamazepine) (adjusted OR 4.07; 95% confidence intervals CI: 3.62–4.57), followed by those prescribed opioids (adjusted OR 2.01; 95% CI: 1.88–2.15) and those prescribed non-opioid analgesics (adjusted OR 1.48; 95% CI: 1.39–1.58) compared to those not prescribed these medications. By individual analgesic, the highest suicide risks were seen in patients prescribed oxycodone (adjusted OR 6.70; 95% CI: 4.49–9.37); pregabalin (adjusted OR 6.50; 95% CI: 5.41–7.81); morphine (adjusted OR 4.54; 95% CI: 3.73–5.52); and gabapentin (adjusted OR 3.12; 95% CI: 2.59–3.75). Suicide risk increased linearly with the number of analgesic prescriptions in the final year (p
- Full text View on content provider's site
-
Danah Kim, Jihoon Lim, Ji Hee Lee, Joohee Choi, Sung Hyun Kwon, Sung-Dae Yim, Young-Jun Sohn, and Seung Geol Lee
- ACS Omega, Vol 8, Iss 35, Pp 31801-31810 (2023)
- Subjects
-
Chemistry and QD1-999
- Full text View on content provider's site
-
Marwan Mansoor Ali Mohammed, Danah Almayeef, Dania Abbas, Maha Ali, Maha Haissam, Rawya Mabrook, Riham Nizar, Tuleen Eldoahji, and Natheer Hashim Al-Rawi
- International Dental Journal, Vol 73, Iss 4, Pp 481-488 (2023)
- Subjects
-
Periodontal disease, Chronic migraine, Headache, Leptin, Chronification, Dentistry, and RK1-715
- Abstract
-
Migraine is a neurologic illness that produces intense throbbing pain on one side of the head and affects roughly 1 billion people worldwide. Recent research indicates a relationship between periodontitis and chronic migraines. This study aimed to review the association between chronic migraines and periodontitis through a systematic literature review.Four research databases (Google Scholar, PubMed, ProQuest, and SpringerLink) were searched according to PRISMA guidelines to retrieve the studies included in this review. A search strategy was developed to answer the study question with appropriate inclusion and exclusion criteria. Out of 34 published studies, 8 studies were included in this review. Three of the studies were cross-sectional, 3 were case-control, and 2 were clinical report and medical hypothesis papers. Seven of the 8 included studies showed that there is an association between periodontal disease and chronic migraine. The elevated blood levels of some biomarkers such as leptins, ProCalcitonin (proCT), calcitonin gene-related peptides (CGRPs), Pentraxin 3 (PTX3), and Soluble Tumor Necrosis Factor-like Weak Inducer Of Apoptosis (sTWEAK) play a significant role in this association. The limitations include a small sample size, the influence of anti-inflammatory drugs, and a self-reported headache measure that is subject to misclassification bias.This systematic review reveals a supposed correlation between periodontal disease and chronic migraine, as evidenced by various biomarkers and inflammatory mediators. This suggests that periodontal disease could potentially contribute to the development of chronic migraine. However, to further assess the potential benefits of periodontal treatment in patients with chronic migraine, additional longitudinal studies with larger sample sizes and interventional studies are needed.
- Full text View on content provider's site
-
Ebtihal Elameen Eltyeb, Majidah Hussain Asiri Halawi, Thekra Badr Mohammed Tashari, Khaled Alharbi, Ohoud Saad Alsayari, Danah Abdullah Albarrak, Raga Abdelkhalig Eltayeb, Ali Ali Ahmed Al-Makramani, and Isameldin Elamin M. Medani
- Pediatric Reports, Vol 15, Iss 3, Pp 431-441 (2023)
- Subjects
-
birth defects, pattern, prevalence, Saudi Arabia, Medicine, Pediatrics, and RJ1-570
- Abstract
-
Introduction: Birth defects are a significant concern since they can lead to permanent disability and death. This study comprehensively reviews the prevalence and patterns of birth defects in Saudi Arabia. Methods: A systematic analysis of the literature retrieved from three databases (Pub Med, Science Direct, and the Saudi digital library) published between 1989 and 2022 was performed. Observational studies that addressed the prevalence and patterns of birth defects in Saudi Arabia were chosen based on the eligibility criteria, while systematic reviews, review articles, non-relevant articles, and studies that did not fulfill the eligibility criteria were excluded. Quality and risk of bias were evaluated based on the JBI and GRADE tools, respectively. Results: We identified 26 eligible publications of 1277 records that included 297,668 patients from different regions of Saudi Arabia. The highest overall prevalence of birth defects was 46.5 per 1000 live births compared to a lowest rate of 8.6 per 1000 in one study. Several studies have reported positive associations of consanguinity, maternal folic acid supplementation, family history of birth defects or genetic abnormalities, and maternal co-morbidities. The most frequent birth defects include cardiac, genitourinary, craniofacial, and nervous system defects. Conclusion: Robust findings have improved our understanding of the prevalence and pattern of birth defects in Saudi Arabia. Importantly, future studies will likely require multicenter collaboration to arrive at appropriate sample sizes in the context of the effects of risk factors on elevated prevalence. Furthermore, quantitative data require careful evaluation in more complex statistical models.
- Full text View on content provider's site
-
Munairah Alshaibani, *, Mays Alajmi, *, Noura Alabduljalil, Hajar Alajmi, Yousef Alsalem, Danah Aloqab, Hamad Alawadhi, Sara Sayed Ali, Yaqoub Sharhan, Ahmed Alzeeny, and Ali H. Ziyab
- Tobacco Induced Diseases, Vol 21, Iss July, Pp 1-13 (2023)
- Subjects
-
electronic cigarettes, adults, dependence, harm, addictiveness, Diseases of the respiratory system, RC705-779, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, and RC254-282
- Abstract
-
Introduction Electronic cigarettes (e-cigarettes) have become one of the most common forms of nicotine delivery used by youth and young adults worldwide. Given the lack of epidemiologic data in Kuwait, this study sought to estimate the prevalence of e-cigarette use, assess perceptions of harm and addictiveness of e-cigarettes, measure the level of dependence on e-cigarettes and assess factors associated with dependence level among adults. Methods A cross-sectional study enrolled adults (n=3032, aged ≥18 years) living in Kuwait using a web-based questionnaire. Participants self-reported ever and current (past 30-day) e-cigarette use and self-completed the 10-item Penn State E-cigarette Dependence Index. Associations were evaluated using multinomial logistic regression. Results The prevalence of ever and current e-cigarette use was estimated to be 40.2% (1220/3032) and 29.4% (892/3032), respectively. The prevalence of current e-cigarette use was higher in males compared to females (47.6% vs 14.4%, p
- Full text View on content provider's site
-
Shams Marzouq Alotaibi, Abdullah Zahlan, Mohammed AlAteeq, Hisham AlMutawa, Nasser Waleed Alobaida, Danah Saleh Aljomah, and Ameen Binnasser
- Otolaryngology Case Reports, Vol 27, Iss , Pp 100516- (2023)
- Subjects
-
Epidermolysis bullosa, Supraglottic stenosis, Laryngeal manifestation, Otorhinolaryngology, and RF1-547
- Abstract
-
Epidermolysis bullosa (EB) is a group of inherited disorders characterized by increased vulnerability to mechanical stress at the dermo-epidermal junction and basilar layer of the epidermis. Laryngeal EB involvement is a major and life-threatening manifestation of the disease. Due to the nature of EB, granulation tissue and stenosis can occur, usually at the glottic, subglottic, or supraglottic levels, as seen in our patients.We described cases in which four patients with EB presented with supraglottic stenosis and were managed at tertiary hospital in Saudi Arabia. The clinical and therapeutic characteristics of all patients are discussed.
- Full text View record in DOAJ
Catalog
Books, media, physical & digital resources
Guides
Course- and topic-based guides to collections, tools, and services.
1 - 20
Next